These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
72 related items for PubMed ID: 12373576
1. Radical trapping in glycogen storage disease 1a. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A. Eur J Pediatr; 2002 Oct; 161 Suppl 1():S70-4. PubMed ID: 12373576 [Abstract] [Full Text] [Related]
2. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A. Free Radic Biol Med; 2002 Jul 01; 33(1):103-10. PubMed ID: 12086688 [Abstract] [Full Text] [Related]
3. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III. Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S. Nutr Metab Cardiovasc Dis; 2009 Jul 01; 19(6):383-90. PubMed ID: 19073362 [Abstract] [Full Text] [Related]
4. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III. Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S. J Trace Elem Med Biol; 2010 Jan 01; 24(1):42-5. PubMed ID: 20122579 [Abstract] [Full Text] [Related]
5. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b. Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Balivo F, Piccolo P, Di Somma C, Colao A, Andria G. J Pediatr; 2010 Apr 01; 156(4):663-70.e1. PubMed ID: 20022338 [Abstract] [Full Text] [Related]
6. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Nguyen AD, Pan CJ, Weinstein DA, Chou JY. Mol Genet Metab; 2006 Nov 01; 89(3):233-8. PubMed ID: 16777453 [Abstract] [Full Text] [Related]
7. Lack of evident atherosclerosis despite multiple risk factors in glycogen storage disease type 1a with hyperadiponectinemia. Tamaki M, Tamura Y, Ogihara T, Shimizu T, Uchino H, Hirose T, Kawamori R, Watada H. Metabolism; 2007 Oct 01; 56(10):1402-4. PubMed ID: 17884452 [Abstract] [Full Text] [Related]
8. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Simão AN, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Nutrition; 2008 Oct 01; 24(7-8):675-81. PubMed ID: 18499396 [Abstract] [Full Text] [Related]
9. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Langley SC, Brown RK, Kelly FJ. Pediatr Res; 1993 Mar 01; 33(3):247-50. PubMed ID: 8460060 [Abstract] [Full Text] [Related]
10. Is glycogen storage disease 1a associated with atherosclerosis? Ubels FL, Rake JP, Slaets JP, Smit GP, Smit AJ. Eur J Pediatr; 2002 Oct 01; 161 Suppl 1():S62-4. PubMed ID: 12373574 [Abstract] [Full Text] [Related]
11. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus. Peerapatdit T, Likidlilid A, Patchanans N, Somkasetrin A. J Med Assoc Thai; 2006 Nov 01; 89 Suppl 5():S141-6. PubMed ID: 17718255 [Abstract] [Full Text] [Related]
12. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a. Bandsma RH, Rake JP, Visser G, Neese RA, Hellerstein MK, van Duyvenvoorde W, Princen HM, Stellaard F, Smit GP, Kuipers F. J Pediatr; 2002 Feb 01; 140(2):256-60. PubMed ID: 11865283 [Abstract] [Full Text] [Related]
13. Serum antioxidant status in streptozotocin-induced diabetic rat. Asayama K, Nakane T, Uchida N, Hayashibe H, Dobashi K, Nakazawa S. Horm Metab Res; 1994 Jul 01; 26(7):313-5. PubMed ID: 7959605 [Abstract] [Full Text] [Related]
14. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients. Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratanasathavorn C. J Med Assoc Thai; 2006 Nov 01; 89 Suppl 5():S147-55. PubMed ID: 17718256 [Abstract] [Full Text] [Related]
15. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Bandsma RH, Prinsen BH, van Der Velden Mde S, Rake JP, Boer T, Smit GP, Reijngoud DJ, Kuipers F. Pediatr Res; 2008 Jun 01; 63(6):702-7. PubMed ID: 18520334 [Abstract] [Full Text] [Related]
16. Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution (1)H NMR spectroscopy. Duarte IF, Goodfellow BJ, Barros A, Jones JG, Barosa C, Diogo L, Garcia P, Gil AM. NMR Biomed; 2007 Jun 01; 20(4):401-12. PubMed ID: 17149801 [Abstract] [Full Text] [Related]
17. [Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2]. Knapik-Kordecka M, Piwowar A, Warwas M. Wiad Lek; 2007 Jun 01; 60(7-8):329-34. PubMed ID: 18175551 [Abstract] [Full Text] [Related]
18. Disturbed lipid metabolism in glycogen storage disease type 1. Bandsma RH, Smit GP, Kuipers F. Eur J Pediatr; 2002 Oct 01; 161 Suppl 1():S65-9. PubMed ID: 12373575 [Abstract] [Full Text] [Related]
19. Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes. Tessier DM, Khalil A, Trottier L, Fülöp T. Arch Gerontol Geriatr; 2009 Oct 01; 48(1):67-72. PubMed ID: 18077012 [Abstract] [Full Text] [Related]
20. Oxidative stress status in patients with diabetes mellitus: relationship to diet. Dierckx N, Horvath G, van Gils C, Vertommen J, van de Vliet J, De Leeuw I, Manuel-y-Keenoy B. Eur J Clin Nutr; 2003 Aug 01; 57(8):999-1008. PubMed ID: 12879095 [Abstract] [Full Text] [Related] Page: [Next] [New Search]